Clinical Trial Update: MRI for Tumor During Chemoradiation for Anal Canal and Perianal Cancer

View source ↗

Summary

A clinical trial investigating MRI-based tumor imaging during chemoradiation for anal canal and perianal cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Perianal Cancer

Snippet

Sponsor: University Health Network, Toronto | Conditions: Anal Cancer Patients, Perianal Patients | Status: WITHDRAWN